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Elevated circulating levels of chemokines have been reported in patients with dengue fever and are proposed
to contribute to the pathogenesis of dengue disease. To establish in vitro models for chemokine induction by
dengue 2 virus (DEN2V), we studied a variety of human cell lines and primary cells. DEN2V infection of HepG2
and primary dendritic cells induced the production of interleukin-8 (IL-8), RANTES, MIP-1, and MIP-1,
whereas only IL-8 and RANTES were induced following dengue virus infection of HEK293 cells. Chemokine
secretion was accompanied by an increase in steady-state mRNA levels. No chemokine induction was observed
in HEK293 cells treated with poly(I:C) or alpha interferon, suggesting a direct effect of virus infection. To
determine the mechanism(s) involved in the induction of chemokine production by DEN2V, individual dengue
virus genes were cloned into plasmids and expressed in HEK293 cells. Transfection of a plasmid expressing
NS5 or a dengue virus replicon induced IL-8 gene expression and secretion. RANTES expression was not
induced under these conditions, however. Reporter assays showed that IL-8 induction by NS5 was principally
through CAAT/enhancer binding protein, whereas DEN2V infection also induced NF-B. These results indi-
cate a role for the dengue virus NS5 protein in the induction of IL-8 by DEN2V infection. Recruitment and
activation of potential target cells to sites of DEN2V replication by virus-induced chemokine production may
contribute to viral replication as well as to the inflammatory components of dengue virus disease.
Dengue virus is a member of the family Flaviviridae and has
a single-stranded RNA genome of positive-strand polarity.
Dengue virus RNA has a type I cap at the 5 terminus and a
single open reading frame flanked by untranslated regions. The
open reading frame encodes a polyprotein precursor which is
co- and posttranslationally processed into three structural pro-
teins (C, prM, and E) and at least seven nonstructural proteins
(NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) (39).
The four serotypes of dengue virus (1, 2, 3, and 4) are
transmitted to humans by Aedes aegypti mosquitoes and cause
dengue, an important viral disease in tropical countries. The
spectrum of dengue illness ranges from a flu-like disease
termed dengue fever to dengue hemorrhagic fever, a fulminant
illness that can progress to dengue shock syndrome and death.
The clinical features of severe dengue disease include hemor-
rhagic diathesis, liver involvement, and plasma leakage, the
latter being the major determinant of disease severity. Cyto-
kine production and T cell activation appear to be important in
dengue hemorrhagic fever pathogenesis (60). Accumulating
evidence indicates that intrinsic properties of the infecting
strain of dengue virus can contribute to the severity of disease
(8, 37, 56, 57).
Chemokines are a family of small, basic, structurally related
chemoattractant cytokines that are expressed upon activation
by various cell types, including T cells, monocytes, and endo-
thelial cells. Chemokines promote the release of granule pro-
teins by granulocytes, promote Th1- or Th2-dependent im-
mune responses, and activate immune cells, including T cells,
NK cells, and monocytes (59). Chemokines have been shown
to play an important role in viral pathogenesis and immunity.
Viruses have found many ways to subvert the chemokine sys-
tem, including virally encoded chemokine/chemokine recep-
tors, altering the expression of chemokine/chemokine recep-
tors, and blocking chemokine receptor signaling pathways (43,
45). On the other hand, viruses can exploit the chemokine
system to enhance viral replication and dissemination of the
virus into neighboring cells (21, 30, 69).
In vitro infection of human myeloid or endothelial cells with
dengue virus has been reported to induce secretion of various
chemokines, including MIP-1, MIP-1, and interleukin-8
(IL-8) (1, 3, 5, 32, 42, 62). Patients with acute dengue were
reported to have elevated levels of chemokines in blood or
pleural fluid (55) and chemokine gene expression in peripheral
blood mononuclear cells (PBMC) (62). These have been
thought to contribute to inflammation and disease pathogen-
esis, however, the mechanism of chemokine induction by den-
gue virus has not been defined.
To study chemokine induction by dengue virus proteins, we
transfected susceptible cells with vectors expressing dengue 2
virus (DEN2V) genes. We found that IL-8 secretion and tran-
scription could be induced by expression of the DEN2V NS5
protein. The effect of the NS5 protein was due to activation of
CAAT/enhancer binding protein (c/EBP) activity and, to a
lesser extent, NF-B activity and activating protein 1 (AP-1).
These results suggest a novel mechanism by which DEN2V
induces chemokine production from infected cells.
MATERIALS AND METHODS
Cells and cell lines. HepG2 (American Type Culture Collection), a human
hepatocarcinoma cell line, was maintained in minimal essential medium supple-
mented with 10% fetal bovine serum, 1.0 mM sodium pyruvate, 0.1 mM nones-
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sential amino acids, penicillin (100 U/ml), and streptomycin (100 g/ml).
HEK293 (American Type Culture Collection) and HEK293A (Invitrogen) were
maintained in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum, 0.1 mM nonessential amino acids, penicillin (100 U/ml), and
streptomycin (100 g/ml).
Dendritic cells. PBMC were obtained by centrifugation using Accuspin tubes
(Sigma). Monocytes were isolated by positive selection using magnetic cell sort-
ing (MACS) according to the manufacturer’s protocol (Miltenyi Biotec). The
CD14 positive cells were cultured in RPMI 1640 supplemented with 10% fetal
bovine serum, rGM-CSF (800u/ml) and rIL-4 (500u/ml) for 5 to 7 days, changing
half the media and adding cytokines every other day. Dendritic cells (DC) were
stained to assess purity with lineage markers (CD3, CD14, CD16, CD56, and
CD20) (fluorescein isothiocyanate), CD1a (phycoerythrin), and HLA-DR (peri-
dinin chlorophyll protein) and analyzed by flow cytometry. Dendritic cells were
85% pure.
Antibodies and cytokines. Fluorescein isothiocyanate-conjugated dengue virus
complex-specific monoclonal antibody (clone M8051125) was obtained from
Fitzgerald Industries International, Inc. DEN2V-specific monoclonal antibody
was derived from a hybridoma cell line, 3H5-1 (American Type Culture Collec-
tion).
Infection with dengue virus. Cells were infected with DEN2V virus strain New
Guinea C strain as previously described (35) at a multiplicity of infection of 1 for
2 h at 37°C. Cells were stained for dengue virus antigen by indirect immunoflu-
orescence on various days postinfection, using 3H5 as the primary antibody and
fluorescein isothiocyanate-conjugated goat anti-mouse immunoglobulin G anti-
body (Sigma Chemical Co., St. Louis, MO) as the secondary antibody. For
experiments using direct immunofluorescence, dengue virus complex–fluorescein
isothiocyanate conjugate antibody was used. The percentage of infected cells was
assessed using flow cytometry.
PBMC samples from patients with acute dengue virus infections. Serial
PBMC samples were studied from 26 children who participated in a prospective
study of acute dengue virus infection (16 with dengue fever and 10 with dengue
hemorrhagic fever) in Thailand (27). Study procedures complied with all relevant
federal guidelines and institutional policies. Patients were enrolled in the study
if they presented within 72 h of the onset of fever. Blood samples were collected
daily until 1 day after defervescence. Convalescent samples were taken 8 to 10
days after enrollment. Fever days were assigned retrospectively as described,
where fever day 0 refers to the day of defervescence. As described previously,
PBMC (approximately 2  106 cells) isolated from whole blood using His-
topaque (Sigma) were resuspended in 1 ml of buffer (4 M guanidine isothiocya-
nate, 40 mM Tris-HCl, pH 6.4, 17 mM EDTA, pH 8.0, 1% Triton X-100), frozen
at	80°C, and shipped on dry ice. Total RNA was prepared using the RNeasy kit
(QIAGEN, Valencia, CA) substituting this lysing buffer for buffer RLT (62).
Virus inactivation. DEN2V was inactivated by UV light. The UV light source
was a Phillips TUV 30W G30T8 UV-C light bulb. The virus was exposed at a
distance of 15 cm for 30 min at room temperature. In addition, DEN2V was heat
inactivated at 56°C for 30 min.
RNA isolation. Total RNA was prepared using the RNeasy kit (QIAGEN)
following the manufacturer’s instructions. For reverse transcription (RT)-PCR,
RNA was treated with DNase according to the manufacturer’s protocol (QIA-
GEN). Viral RNA was isolated from supernatants of DEN2V-infected cells
using the QIAmp viral RNA kit (QIAGEN) following the manufacturer’s pro-
tocol.
RNase protection assay. The human chemokine multiprobe template set
(hCK-5) was used to make the radiolabeled probe according to the manufactur-
er’s protocol (Riboquant, Pharmingen). The RNase protection assay was per-
formed according to the manufacturer’s protocol (Torrey Pines Biolabs, Inc.).
Briefly, equal amounts of total cellular RNA were hybridized to 32P-labeled
riboprobe cocktail hCK-5. The hybridized RNA was digested by RNase A. The
precipitated RNA was electrophoresed on a denaturing acrylamide gel and the
bands were detected by autoradiography. The specific chemokine bands were
identified on the basis of their individual migration patterns in comparison with
the undigested probes. The bands were quantified by densitometric analysis using
Image Quant densitometric software. Glyceraldehyde-3-phosphate dehydroge-
nase and L32 were used as internal controls.
ELISA. MIP-1, MIP-1, MCP-1, IL-8, and RANTES protein concentrations
were determined in cell culture supernatants using commercially available en-
zyme-linked immunosorbent assay (ELISA) kits according to the manufacturer’s
instructions (R&D Systems).
Quantitative RT-PCR. For quantitation of IL-8 mRNA, 200 nanograms of
total cellular RNA was used to synthesize cDNA using Omniscript reverse
transcriptase and oligo(dT) primers following the manufacturer’s protocol (QIA-
GEN). PCR was performed in triplicate using TaqMan IL-8 and -actin primers
and probes (Applied Biosystems) and the Gene Amp 5700 Sequence Detection
System. For quantitation of mRNA, a standard curve of control DNA was
generated and samples were normalized to the endogenous -actin control. The
ratios of infected or transfected cells versus uninfected or untransfected cells,
respectively, were calculated.
For DEN2V quantitation from supernatants of virally infected cells, cDNA
was synthesized from isolated viral RNA using Multiscribe reverse transcriptase
(Applied Biosystems) and the reverse DEN2V primer following the manufac-
turer’s instructions. PCR was performed using the Taqman Universal PCR
master mix and DEN2V forward and reverse primers and a DEN2V-specific
probe and the GeneAmp 7300 sequence detection system (Applied Biosystems)
as described previously (20). Quantitation of viral RNA was performed using a
standard curve of DEN2V viral RNA to determine copies of viral genome in
supernatants of virally infected cells.
Plasmids. The replicon which contains the DEN2V NGC genome with the
prM and E genes deleted was kindly provided by Andrew Dayton (52). Four
luciferase reporter constructs containing the IL-8 promoter were used; one
contained the wild-type binding sites for NF-B, AP-1, and c/EBP, and the other
three contained mutant binding sites for NF-B (GGAATTTCCT to TAACTT
TCCT from 	80 to 	71), AP-1 (TGACTCA to TATCTCA from 	126 to
	120), or c/EBP (CAGTTGCAAATCGT to AGCTTGCAAATCGT from 	94
to 	81); all were generously provided by Naofumi Mukaida (Kanazawa Univer-
sity, Japan) (50). In addition, luciferase reporter constructs containing tandem
repeat binding sites for NF-B, AP-1, and c/EBP were used (Strategene). Plas-
mids expressing signaling molecules Mal, MEKK1, or TBK1 and the interferon-
stimulated regulatory element (ISRE) of the IFIT2 gene encoding ISG54 were
previously described (10, 11). The pcDNA3.1 plasmid was obtained from Invitro-
gen.
Primers were designed for PCR amplification and cloning of each of the
DEN2V genes (Table 1). Each 5 and 3 primer contained attB1 and attB2
sequences, respectively, for homologous recombination into the Gateway entry
vector pDONR201 (Invitrogen). The prM, E, and NS1 forward primers included
the putative leader sequences (9, 15, 22, 46).
PCR was performed using rTth DNA polymerase (Applied Biosystems) and
DEN2V infectious clone, which was created using DEN2V NGC as the template
(kindly provided by Barry Falgout, Food and Drug Administration) (53). The
PCR product was cloned into pDONR201 by homologous recombination using
Gateway Technology following the manufacturer’s instructions. Mammalian ex-
pression vectors were made by homologous recombination of each dengue virus
gene into the pDEST40 vector or pDEST47 as described in the Gateway Tech-
nology manual (Invitrogen). The identities of the clones were confirmed by DNA
sequencing. All plasmids were isolated with an Endofree maxiplasmid kit (QIA-
GEN).
Transfections. HEK293A cells were transfected using Effectene (QIAGEN)
following the manufacturer’s instructions. Briefly, HEK293A cells were seeded
onto six-well plates at 2 105 cells per well 24 h before transfection. To transfect,
0.6 g of dengue virus protein-expressing plasmid and 0.2 g of lacZ-expressing
plasmid were diluted in EC buffer (QIAGEN) for each condition. In addition, 6.4
l of Enhancer (QIAGEN) was added to the mixture and incubated for 2 min at
room temperature. The mixture was spun down; 8 l of Effectene (QIAGEN)
was added and incubated for 5 min at room temperature. Growth medium was
added to the mixture and the complex was added to the cells. Transfection
efficiency was approximately 30% as assessed by -galactosidase staining follow-
ing the manufacturer’s protocol (Invitrogen).
Luciferase reporter gene assay. HEK293A cells maintained in Dulbecco’s
modified Eagle’s medium-10% fetal bovine serum at 37°C were plated in a
96-well plate at 2  104 cells/ml. After 24 h, the cells were transfected with
reporter plasmids and/or expression plasmids using Genejuice according to the
manufacturer’s protocol (Novagen). Twenty-four hours (for plasmids) and 72 or
96 h (for virus) later, cells transfected with expression plasmids were lysed, and
the luciferase activity was determined. A Renilla reniformis luciferase reporter
under the control of the herpes simplex virus thymidine kinase promoter, pRL-
TK, was used as an internal control to normalize reporter gene activity. Lucif-
erase activities were determined by a luminometer using the dual-luciferase
reporter assay according to the instructions of the manufacturer (Promega Co.).
All conditions were tested in triplicate. At least two independent experiments
were performed for each assay.
RESULTS
Induction of chemokine secretion and gene expression by
DEN2V. It is unclear which cells are primary targets of dengue
virus infection in vivo. In vivo studies suggest monocytes and
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lymphocytes are important targets, but these cell types are not
highly susceptible to dengue virus infection in vitro (24, 64, 70).
Dengue virus antigen has also been found in hepatocytes and
endothelium from biopsies of dengue hemorrhagic fever pa-
tients (6, 16, 24, 58). In vitro, dengue virus can productively
infect many cell types. To find a cell line(s) that would facilitate
in vitro studies of dengue virus-induced chemokine induction,
we assessed chemokine induction by DEN2V infection in var-
ious cell lines, including myelomonocytic cell lines U937, K562,
and Thp-1, hepatoma cell line HepG2, endothelial cell line
ECV304, and embryonic kidney cell line HEK293.
Of the cell lines tested, HepG2 and HEK293 cells were most
susceptible to DEN2V infection and both produced chemo-
kines in response to DEN2V infection (Table 2). DEN2V-
infected HepG2 cells secreted IL-8, RANTES, MIP-1, and
MIP-1. Only IL-8 and RANTES were expressed in DEN2V-
infected HEK293 cells, indicating a unique chemokine profile
for each cell type. The secretion level of chemokines in both
cell lines peaked late in infection, between days 3 and 5. In
comparison, DEN2V RNA levels in culture supernatants of
HepG2 and HEK293 cells reached maximum values (
107
genome copies/ml) by 48 h postinfection (data not shown).
To assess whether protein expression of each chemokine is
regulated at the transcriptional level or during translation,
chemokine mRNA levels in HepG2 cells were analyzed by
RNase protection assay (Fig. 1). DEN2V infection induced the
expression of IL-8, RANTES, MIP-1, MIP-1, and IP10
mRNAs. The level of mRNA peaked between days 3 through
5, which was similar to the kinetics of protein expression.
Chemokine production by dengue virus in primary human
cells infected in vitro and by PBMC in vivo. Chemokine in-
duction has been shown in primary monocytes following den-
gue virus infection (3, 5). Since dendritic cells have also been
proposed as an important target for dengue virus infection in
vivo, we isolated monocytes from PBMC and cultured them for
7 days with IL-4 and granulocyte-macrophage colony-stimulat-
ing factor to generate myeloid dendritic cells (17, 70). The
dendritic cells were infected with DEN2V at a multiplicity of
infection of 1. Culture supernatants were collected 24 h postin-
fection and chemokine levels were determined by ELISA.
TABLE 1. Primers used for cloning of dengue virus genes
Primera Sequence (5 3 3)b
C (forward) GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGAATAACCAACGAAAAAAGGCGAG
C (reverse) GGGGACCACTTTGTACAAGAAAGCTGGGTCCGCCATCACTGTTGGAATCAGC
prM (forward) GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGAGAACTGCAGGCATGATCATTATGCTGATTC
prM (reverse) GGGGACCACTTTGTACAAGAAAGCTGGGTCCTATGTCATTGAAGGAGCGACAGCTG
E (forward) GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGAGAGCCCTGATTTTCATCTTACTGACAG
E (reverse) GGGGACCACTTTGTACAAGAAAGCTGGGTCCTAGGCCTGCACCATAACTCCCAAATAC
NS1 (forward) GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGAATTCACGCAGCACCTCACTG
NS1 (reverse) GGGGACCACTTTGTACAAGAAAGCTGGGTCGGCTGTGACCAAGGAGTTGAC
NS2A (forward) GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGGGACATGGGCAGATTGACAACTTTTCA
NS2A (reverse) GGGGACCACTTTGTACAAGAAAGCTGGGTCCCTTTTCTTGTTGGTTCTTGAAAGGGTTG
NS2B (forward) GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGAGCTGGCCACTAAATGAGGCTATCA
NS2B (reverse) GGGGACCACTTTGTACAAGAAAGCTGGGTCCCGTTGTTTCTTCACTTCCCACAG
NS3 (forward) GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGGCTGGAGTATTGTGGGATGTCC
NS3 (reverse) GGGGACCACTTTGTACAAGAAAGCTGGGTCCTTTCTTCCAGCTGCAAACTCCTTGAATT
NS4A (forward) GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGTCCCTGACCCTGAACCTAATCACA
NS4A (reverse) GGGGACCACTTTGTACAAGAAAGCTGGGTCTCTTTTCTGAGCTTCTCTGGTTGCTTTTG
NS4B (forward) GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGGCAGGAGCGGGCATCATGAAAA
NS4B (reverse) GGGGACCACTTTGTACAAGAAAGCTGGGTCCCTTCTCGTGTTGGTTGTGTTCTTCAT
NS5 (forward) GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGGGAACTGGCAACATAGGAGAGAC
NS5 (reverse) GGGGACCACTTTGTACAAGAAAGCTGGGTCCCACAGGACTCCTGCCTCTT
a Primer names indicate the gene amplified for cloning.
b Bold sequence is the dengue virus sequence, and underlined sequences are added stop codons.
TABLE 2. Chemokine production from DEN2V-infected HepG2 and HEK293 cell linesa
Cells Chemokine
Production (pg/ml)
Day 1 Day 2 Day 3 Day 4 Day 5
DEN2V Medium DEN2V Medium DEN2V Medium DEN2V Medium DEN2V Medium
HepG2 IL-8b 11 3 44 0 97 0 164 5 168 0
RANTESb 4 2 73 0 427 0 1,350 1 1,721 3
MIP-1 48 4 480 5 873 5 819 7 669 5
MIP-1 6 8 22 7 67 6 284 9 623 8
HEK293 IL-8b 0 0 0 0 18 0 69 0 138 0
RANTES 0 2 6 1 64 1 110 0 NDc ND
a Cell lines were infected with DEN2V NGC at a multiplicity of 1. Both HEK293 and HepG2 cell lines were infected 25 to 30% with DEN2V NGC by day 1 as
assessed by flow cytometry (data not shown).
b Results are representative of three experiments.
c ND, not determined.
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IL-8, RANTES, MIP-1, MIP-1, and MCP-1 levels were sig-
nificantly higher in cultures of infected dendritic cells (Table
3). The results indicate that chemokine induction by DEN2V is
also detected in primary cells, which are relevant to in vivo
infection.
To determine whether IL-8 gene expression also occurs in
vivo during dengue virus infections, we analyzed IL-8 mRNA
levels in PBMC collected from 26 subjects with acute dengue
virus infections using quantitative RT-PCR. All subjects had
dengue virus viremia detected by RT-PCR at the time of entry
into the study (63). IL-8 mRNA levels were numerically ex-
pressed as Ct values relative to -actin mRNA levels. As
shown in Fig. 2, IL-8 mRNA was detected in PBMC from all
subjects tested. Mean IL-8 mRNA levels were highest later in
infection, towards the end of the febrile period (fever days 	1
to 0), especially in subjects with dengue hemorrhagic fever.
IL-8 induction requires replication-competent virus and is
not due to IFN-. To assess whether the IL-8 expression in
HepG2 cells was due to DEN2V antigen or replicating virus,
DEN2V was heat inactivated or UV inactivated. The virus was
added to HepG2 cells at a multiplicity of infection of 1 for 2 h
at 37°C and supernatants were collected daily for analysis of
IL-8 expression by ELISA. Viral progeny was measured in the
supernatants of HepG2 cells. Supernatants from DEN2V-in-
fected HepG2 cells contained approximately 106 PFU/ml by
day 3, whereas infectious DEN2V was not detected in the
supernatants from HepG2 cells treated with UV or heat inac-
tivated virus (data not shown). As seen in Fig. 3, IL-8 secretion
was induced only in cells infected with live DEN2V.
We considered the possibility that induction of IL-8 in cells
infected with DEN2V was due directly or indirectly through
induction of alpha interferon (IFN-) production. Neither
poly(I:C) nor IFN- treatment of cells induced IL-8 expres-
sion. However, phorbol myristate acetate and ionomycin in-
duced IL-8 secretion by 3 h poststimulation in HepG2 cells and
by 8 h in HEK293 cells (data not shown).
Expression of NS5 is sufficient to induce expression of IL-8
but not RANTES. To define further the mechanism for induc-
tion of chemokine production by DEN2V infection, we studied
the effects of expression of individual DEN2V proteins or a
DEN2V replicon. The plasmids were transfected into
HEK293A cells and supernatants were collected on day 2. As
shown in Fig. 4A, the replicon induced IL-8 protein expression
sixfold over the lacZ control plasmid. NS5 also induced expres-
FIG. 1. Chemokine mRNA expression from HepG2 cell line in-
fected with DEN2V. HepG2 cells were infected with DEN2V at a
multiplicity of infection of 1. Total RNA was isolated for each time
point after viral infection. Detection and quantification of the indi-
cated human chemokine mRNAs were analyzed by RNase protection
assay as outlined in Materials and Methods. P, probe lane; D, day; ,
infection with DEN2V; and 	, mock infection.
FIG. 2. IL-8 gene expression in PBMC of patients with acute den-
gue virus infection. Total RNA was isolated from serial PBMC samples
obtained from 16 subjects with dengue fever (DF) and 10 subjects with
dengue hemorrhagic fever (DHF). IL-8 and -actin mRNA levels were
measured by quantitative RT-PCR using TaqMan primers and probes.
IL-8 mRNA levels are expressed as the difference in Ct between -ac-
tin and IL-8. Values represent the mean standard error of the mean.
F/u, follow-up visit, approximately 1 week after defervesence.
FIG. 3. IL-8 expression in HepG2 cells requires replication com-
petent DEN2V. UV- and heat-inactivated virus, untreated virus, and
C6/36 supernatants were added to HepG2 cells for 5 days. Superna-
tants were analyzed for IL-8 protein by ELISA.
TABLE 3. DEN2V induces chemokines in dendritic cells
Chemokine
Production (pg/ml)
DEN2V C6/36 Medium
IL-8 17,600 220 400
RANTES 12,700 11 6
MCP-1 2,100 440 520
MIP-1 8,980 70 70
MIP-1 17,300 300 180
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sion of IL-8, with levels threefold over the lacZ control plas-
mid. However, there was no RANTES secretion in cells trans-
fected with either NS5 or the replicon (data not shown). The
levels of IL-8 mRNA expression measured by RT-PCR corre-
lated with IL-8 protein secretion from cells transfected with the
plasmid expressing NS5 or the replicon (Fig. 4B). These results
show that IL-8 expression can be induced by the NS5 protein.
NS5 and replicon do not activate ISRE or RANTES. The
RANTES promoter contains binding elements for transcrip-
tion factors NF-B, and interferon-regulated factor 3 (IRF-3)
(13, 41). IRF-3 has been shown to bind to the ISRE domain in
the RANTES promoter to induce RANTES expression during
viral infection (41). We wanted to analyze the ability of NS5,
replicon, and DEN2V to activate the interferon-stimulated
regulatory element (ISRE) as well as RANTES and IL-8 pro-
moters (Fig. 5). The IKK-related kinase TBK1 has recently
been shown to phosphorylate and activate IRF-3; overexpres-
sion of TBK1 induced transcription from both the ISRE and
RANTES promoters (positive control), consistent with pub-
lished reports (10, 61). Similarly, overexpression of Mal, the
TLR4 adaptor molecule, induced transcription from the IL-8
promoter (positive control), as previously reported (11, 14).
Neither NS5 nor the replicon activated the ISRE reporter or
induced the RANTES promoter, whereas DEN2V infection
activated ISRE 13-fold and RANTES fivefold 72 h postinfec-
tion.
Transcription factors induced by NS5 and DEN2V. The
transcription factors involved in IL-8 mRNA induction include
c/EBP, AP-1, and NF-B (19). To identify the transcription
factors that are induced by NS5 and DEN2V, we used promot-
ers that contain multiple copies of binding sites for c/EBP,
AP-1, or NF-B. Mal or MEKK1 (mitogen-activated protein
kinase kinase), as positive controls, induced transcription from
the NF-B and AP-1 reporter constructs, as previously re-
ported (7, 11). NS5 induced c/EBP-driven transcription seven-
fold, AP-1 fivefold, and NF-B less than twofold over the
control plasmid (Fig. 6A). DEN2V infection induced c/EBP
1.5-fold, AP-1 twofold, and NF-B threefold over the control
(Fig. 6B). These results suggest activation of c/EBP, AP-1, and
NF-B by DEN2V infection and NS5 expression.
To further assess the transcription factors important for
induction of IL-8, IL-8 reporter constructs containing muta-
tions in the binding site for c/EBP (mtc/EBP), AP-1 (mtAP-1),
or NF-B (mtNF-B) were tested (50). As shown in Fig. 7A, a
FIG. 4. NS5 and DEN2V replicon induce IL-8 expression from
HEK293A cells. (A) Plasmids expressing DEN2V proteins or replicon
were transfected into HEK293A cells. Supernatants were harvested
day 2 posttransfection and analyzed for IL-8 protein by ELISA. (B) IL-8
mRNA levels from HEK293A cells transfected with NS5 plasmid,
replicon, or untransfected cells were assessed by Taqman PCR on day
2 posttransfection. Results are normalized to untransfected cells (
100).
FIG. 5. NS5 and DEN2V replicon do not activate the ISRE or
RANTES promoter. HEK293A cells were transfected with a vector
containing a reporter gene for ISRE, RANTES, or IL-8 and (A) co-
transfected with an expression vector for NS5 or replicon or (B) in-
fected 24 h later with DEN2V. After 24 h (NS5 and replicon) or 72 h
(DEN2V), luciferase reporter gene activity was measured and data
were normalized to transfection efficiency with Renilla reniformis lu-
ciferase.
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mutation in the c/EBP binding site within the IL-8 promoter
reduced activation by NS5 twofold compared with the wild-
type IL-8 promoter. A mutation in the NF-B binding site had
a modest effect on IL-8 transcription (1.5-fold reduction) com-
pared to the wild-type IL-8 promoter. However, a mutation in
the AP-1 binding site enhanced NS5-driven transcription from
the IL-8 promoter by almost twofold. These results suggest
that c/EBP is a dominant component in the induction of the
IL-8 promoter by NS5. In contrast, AP-1 did not have a pre-
dominant effect on IL-8 induction by NS5 and may even be
inhibitory.
Transcription from the mtc/EBP, mtAP-1, and mtNF-B
IL-8 promoters was reduced twofold compared to the wild-
type IL-8 promoter by day 4 postinfection with DEN2V (Fig.
7B). These results suggest that c/EBP, AP-1, and, in addition,
NF-B are important for IL-8 induction during DEN2V infec-
tion. This suggests an additional mechanism for IL-8 induction
by DEN2V infection that includes NF-B activation.
DISCUSSION
Our results demonstrate that DEN2V infection of diverse
human cell lines can induce the production of multiple che-
mokines in vitro, which is similar to previous results (1, 3, 5, 32,
62). Each cell line had a unique chemokine induction profile.
These differences may be explained by differences in the ex-
pression of transcription factors in each cell type (23, 44).
Dendritic cells expressed IL-8, RANTES, MCP-1, MIP-1,
and MIP-1 as early as 24 h postinfection. This could reflect
the role that dendritic cells play as sentinels of the immune
system (44). In contrast, the chemokines analyzed in this study
peaked late, 3 to 5 days after DEN2V infection, for all the cell
lines we tested. A similar profile was found in primary mono-
cytes/macrophages (5). Possible explanations for the delay in
chemokine expression could be a need for the virus to reach a
threshold of viral load to induce chemokines, a need for tran-
scription factors involved in chemokine induction to be in-
duced, or a time delay in protein translocation into the nucleus.
We have shown an increase in steady-state chemokine mRNAs
over time during DEN2V infection of cell lines. Although we
have not excluded the possibility that increased chemokine
secretion is due to mRNA stabilization, as has been reported
FIG. 6. Transcription factors activated by NS5 and DEN2V.
HEK293A cells were cotransfected with vector encoding a reporter
gene for IL-8, c/EBP, AP-1, or NF-B and (A) an expression vector for
NS5 or (B) infected after 24 h with DEN2V. After 24 h (NS5) or 96 h
(DEN2V), luciferase gene activity was measured and data are normal-
ized to transfection efficiency with R. reniformis luciferase. There is a
statistically significant difference (P  0.01) between DEN2V- and
C6/36-treated cells for the IL-8, c/EBP, AP-1, and NF-B reporters.
FIG. 7. Effect of NS5 expression or DEN2V infection on transcrip-
tion from luciferase-mutated IL-8 promoters. HEK293A cells were
cotransfected with vector encoding a reporter gene for IL-8, mtc/EBP,
mtAP-1, and mtNF-B and (A) an expression vector for NS5 or (B) in-
fected after 24 h with DEN2V. After 24 h (NS5) or 96 h (DEN2V),
luciferase gene activity was measured and data are normalized to
transfection efficiency with R. reniformis luciferase. There is a statisti-
cally significant difference (P  0.01) between DEN2V- and C6/36-
treated cells for the IL-8, mtc/EBP, mtAP-1, and mtNF-B reporters.
mtc/EBP, mtAP-1, and mtNF-B represent the 133-luc plasmid with
point mutations in the NF-IL-6, AP-1, and NF-B binding sites, re-
spectively.
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with respiratory syncytial virus and RANTES expression and
for adenovirus and IL-8 (33, 38), we have shown that transcrip-
tion from the IL-8 promoter was induced by DEN2V infection
through activation of transcription factors NF-B, AP-1, and
c/EBP.
Viral infection of a host cell activates signaling pathways that
lead to IFN production as a consequence of double-stranded
RNA intermediates from viral replication. In this regard the
RNA helicase RIG-I has recently been identified as a cytoplas-
mic double-stranded RNA sensing mechanism. The RIG-I
pathway elicits the activation of transcription factors such as
NF-B and IRF3 that are also involved in chemokine tran-
scription (71). Although we have reported that induction of
IL-8 production by DEN2V occurs independently of IFN-, it
will be interesting to determine if RIG-I plays a role in
DEN2V detection and signaling.
Our finding of IL-8 induction by NS5 reveals a novel mech-
anism for DEN2V-induced chemokine production. Dengue
virus NS5 is a large multifunctional protein containing an S-
adenosylmethionine transferase domain in the N-terminal re-
gion (34) and an RNA-dependent RNA polymerase domain in
the C-terminal region (49, 66). NS5 was shown to be differen-
tially phosphorylated and located in both the cytosol and the
nucleus (28). In the late stage of infection, NS5 becomes hy-
perphosphorylated and dissociates from NS3, exposing a nu-
clear localization signal (25, 28). The function of nuclearly
localized NS5 has not been identified. The kinetics of IL-8
secretion late in infection correlates with movement of NS5 to
the nucleus (28). It is possible that nuclear NS5 can bind
directly or indirectly to the IL-8 promoter to induce gene
expression.
It has been shown that different strains of DEN2V (i.e.,
American versus Asian genotypes) are associated with various
degrees of disease (57). Previous research compared sequences
of the Asian genotype of DEN2V, which is associated with
dengue hemorrhagic fever, and the American genotype, which
appears to be incapable of causing dengue hemorrhagic fever
(37). Five of the eight amino acid differences between geno-
types within the nonstructural proteins that led to an amino
acid change were located in the N terminus of NS5. We con-
structed the NS5 expression plasmid from the infectious cDNA
clone of Polo et al. (53), derived from the DEN2V strain New
Guinea C, a member of the Asian genotype. It will be inter-
esting to determine whether sequence differences within NS5
change the ability of the protein to induce IL-8.
High local levels of IL-8 are associated with pleural effusion
(2, 51). IL-8 has been shown to be elevated in serum and
PBMC of patients with the more severe dengue virus disease
dengue hemorrhagic fever (26, 55). A recent paper has shown
that IL-8 can alter the cytoskeleton and tight junctions of
microvascular endothelium and change the permeability of the
endothelial monolayer (65). The general mechanism of IL-8
induction is through the cytokine network that includes IL-1
and tumor necrosis factor alpha (19). During dengue virus
infection, tumor necrosis factor alpha and IL-1 are induced in
dengue fever and dengue hemorrhagic fever patients and may
induce low levels of IL-8 (4, 18). Previously, it has been re-
ported that dengue hemorrhagic fever patients tend to have a
higher viral burden early in infection (40, 68), which may cor-
relate with increased NS5 expression. The increase in NS5 may
elevate levels of IL-8 and contribute to the altered vascular
permeability seen in patients with dengue hemorrhagic fever.
We found that the mean levels of IL-8 mRNA in PBMC were
higher later during dengue virus infection. Although we did not
find statistically significant differences in IL-8 mRNA levels
between dengue fever and dengue hemorrhagic fever patients,
it should be noted that mean viremia titers were not signifi-
cantly different in the dengue hemorrhagic fever patients com-
pared to dengue fever patients in this sample of subjects (63).
IL-8, a proinflammatory CXC chemokine, is induced in mul-
tiple cell types by many stimuli, including viruses (31). IL-8
induces a respiratory burst of neutrophils, release of lytic en-
zymes, platelet-activating factor, and leukotrienes, which are
all inflammatory reactions to rid the host of invading patho-
gens (2). IL-8 induction has been found to counteract the
antiviral effects of IFN- and enhance viral replication of many
viruses, including picornovirus, encephalomyocarditis virus,
poliovirus, cytomegalovirus, and human immunodeficiency vi-
rus (30, 36, 48, 54).
Hepatitis C virus, a distant relative of dengue virus in the
family Flaviviridae, has been shown to counteract the type I
IFN response. The HCV NS5A and E2 proteins prevent phos-
phorylation of eIF2 and the arrest of viral translation by
inhibiting double-stranded RNA-dependent protein kinase R
activity (12, 67). In addition, the core and NS5A proteins of
hepatitis C virus were able to activate the IL-8 promoter (29,
54). Recently, DEN2V NS4B has been shown to inhibit the
IFN-induced signal transduction cascade by interfering with
STAT1 function (47). Our data shows that the dengue virus
NS5 protein can induce expression of IL-8. DEN2V may use
this mechanism to counteract the antiviral effects of innate
immunity, allowing further dissemination of the virus to neigh-
boring uninfected cells.
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